Samar Al Emadi

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Dimensionality reduction reveals fine-scale structure in the Japanese population with consequences for polygenic risk prediction

Saori Sakaue, Jun Hirata, Masahiro Kanai et al. · Nature Communications · 2020 · 119 citations · Full text

Life Sciences, Biology, Genetics +17

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 116 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Manuel F. Ugarte‐Gil, Graciela S. Alarcón, Zara Izadi et al. · Annals of the Rheumatic Diseases · 2022 · 92 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +14

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

Jean W. Liew, Milena Gianfrancesco, Carly Harrison et al. · RMD Open · 2022 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13